Metastectomy for combined hepatic and extrahepatic colorectal cancer metastases

Current Colorectal Cancer Reports

Volumn 3, Issue 2, 2007, Pages 89-93

  Beaty, Karen A ^a   Curley, Steven A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59849083972     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-007-0006-6     Document Type: Article

References (25)

1. Hughes KS, Simon R, Songhorabodi S, et al.: Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of patterns of recurrence. Surgery 1986, 100:278-284.
2. Nordlinger B, Guiguet M, Vaillant JC, et al.: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996, 77:1254-1262.
3. Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-321.
4. Scheele J, Altendorf-Hofmann A, Grube T, et al.: Resection of colorectal liver metastases. What prognostic factors determine patient selection? [in German]. Chirurg 2001, 72:547-560.
5. Scaife CL, Ng CS, Ellis LM, et al. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol 13:1-5, 2006.
6. Conlon R, Jacobs M, Dasgupta D, Lodge JP: The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 2003, 16:211-216.
7. Aloia TA, Vauthey JN, Loyer EM, et al.: Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006, 141:460-467.
8. Levi F, Zidani R, Brienza S, et al.: A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. Cancer 1999, 85:2532-2540.
9. Douillard JY, Cunningham D, Roth AD, et al.: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000, 355:1041-1047.
10. Published erratum appears in Lancet 2000, 355:1372.
11. Giacchetti S, Perpoint B, Zidani R, et al.: Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2000, 18:136-147.
12. de Gramont A, Figer A, Seymour M, et al.: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000, 18:2938-2947.
13. Goldberg RM, Sargent DJ, Morton RF, et al.: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [see comment]. J Clin Oncol 2004, 22:23-30.
14. Varadhachary GR, Hoff PM: Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy. Semin Oncol 2005, 32:S40-42.
15. Goldberg RM: Advances in the treatment of metastatic colorectal cancer. Oncologist 2005, 10:40-48.
16. Chong G, Cunningham D: The role of cetuximab in the therapy of previously treated advanced colorectal cancer. Semin Oncol 2005, 32:S55-S58.
17. Marshall J: The role of bevacizumab as first-line-therapy for colon cancer. Semin Oncol 2005, 32:S43-47.
18. Adam R, Delvart V, Pascal G, et al.: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004, 240:644-658.
19. Minagawa M, Makuuchi M, Torzilli G, et al.: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000, 231:487-499.
20. Elias D, Ouellet JF, Bellon N, et al.: Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003, 90:567-574.
21. Ashley AC, Deschamps C, Alberts SR: Impact of prognostic factors on clinical outcome after resection of colorectal pulmonary metastases. Clin Colorectal Cancer 2006, 6:32-37.
22. Regnard JF, Grunenwald D, Spaggiari L, et al.: Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 1998, 66:214-219.
23. Kobayashi K, Kawamura M, Ishihara T: Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg 1999, 118:1090-1096.
24. Shah SA, Haddad R, Al-Sukhni W, et al.: Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006, 202:468-475.
25. Mineo TC, Ambrogi V, Tonini G, et al.: Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 2003, 197:386-391.